These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2839672

  • 1. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D, Bayer L, Strupp BJ.
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [Abstract] [Full Text] [Related]

  • 3. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V, Piasek M, Blanusa M, Matek Sarić M, Juresa D, Kostial K.
    J Appl Toxicol; 2004 Aug; 24(2):123-8. PubMed ID: 15052607
    [Abstract] [Full Text] [Related]

  • 4. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.
    Cory-Slechta DA, Weiss B, Cox C.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):804-13. PubMed ID: 3121845
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ, Pande M, Kannan GM, Mehta A.
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [Abstract] [Full Text] [Related]

  • 11. Chelated lead in relation to lead in bone and ALAD genotype.
    Gerhardsson L, Börjesson J, Mattsson S, Schütz A, Skerfving S.
    Environ Res; 1999 May; 80(4):389-98. PubMed ID: 10330313
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S, Vale A.
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [Abstract] [Full Text] [Related]

  • 14. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB, Anderson RL, Super DM.
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
    Aslani MR, Najarnezhad V, Mohri M.
    Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.